Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.

Ikuta M, Kornienko M, Byrne N, Reid JC, Mizuarai S, Kotani H, Munshi SK.

Protein Sci. 2007 Dec;16(12):2626-35. Epub 2007 Oct 26.

2.

Cross-talk between protein kinase A and the MAPK-activated protein kinases RSK1 and MK5.

Kostenko S, Shiryaev A, Dumitriu G, Gerits N, Moens U.

J Recept Signal Transduct Res. 2011 Feb;31(1):1-9. doi: 10.3109/10799893.2010.515593. Epub 2010 Sep 18. Review.

PMID:
20849292
3.

The RSK factors of activating the Ras/MAPK signaling cascade.

Carriere A, Ray H, Blenis J, Roux PP.

Front Biosci. 2008 May 1;13:4258-75. Review.

PMID:
18508509
4.

The RSK family of kinases: emerging roles in cellular signalling.

Anjum R, Blenis J.

Nat Rev Mol Cell Biol. 2008 Oct;9(10):747-58. doi: 10.1038/nrm2509. Review.

PMID:
18813292
5.

The protein kinase activity modulation sites: mechanisms for cellular regulation - targets for therapeutic intervention.

Engh RA, Bossemeyer D.

Adv Enzyme Regul. 2001;41:121-49. Review. No abstract available.

PMID:
11384741
6.

Regulation and function of the RSK family of protein kinases.

Romeo Y, Zhang X, Roux PP.

Biochem J. 2012 Jan 15;441(2):553-69. doi: 10.1042/BJ20110289. Review.

PMID:
22187936
7.

The unusual mechanism of inhibition of the p90 ribosomal S6 kinase (RSK) by flavonol rhamnosides.

Utepbergenov D, Derewenda ZS.

Biochim Biophys Acta. 2013 Jul;1834(7):1285-91. doi: 10.1016/j.bbapap.2013.03.018. Epub 2013 Mar 27. Review.

Supplemental Content

Support Center